03:10 AM EDT, 05/06/2024 (MT Newswires) -- Greg Zante, Chief Financial Officer, on May 03, 2024, sold 66,756 shares in Viking Therapeutics ( VKTX ) for $4,986,008. Following the Form 4 filing with the SEC, Zante has control over a total of 174,854 shares of the company, with 174,854 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1607678/000120919124005522/xslF345X03/doc4.xml

Price: 77.00, Change: +0.03, Percent Change: +0.04